1990 ,
The FDA followed in August 2025 with an accelerated approval of Novo Nordisks Wegovy (semaglutide) for adults with noncirrhotic MASH and moderate-to-advanced fibrosis, the first GLP-1 therapy cleared for the condition albeit contingent on confirmatory evidence
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur
In the LEAN trial, Liraglutide was shown to have a higher rates of NASH resolution and lower rates of fibrosis progression compared to placebo
L-carnitine is a compound your body makes naturally from two amino acids, lysine and methionine, primarily in your liver and kidneys
137 As a sulfur-containing amino acid, it possesses two potential binding sites for metals and is capable of binding and sequestering divalent copper (II), trivalent iron (III), lead, mercury, and cadmium ions